Knowledge Center

Leading health care systems, clinical laboratories, vendors and health plans are all increasing their focus on providing precision medicine (PM) through the use of genetic and genomic information. Venture capital funding has increased exponentially in this space, with new technologies and applications emerging for researchers, health care providers, and their patients. On top of this, we see how breathlessly new technology is being developed to further advance clinical genomics. Before many health systems have their programs fully functioning, the industry is already talking about artificial intelligence and machine learning ventures as required investments.